Skip to content

Electrical Storm and Incessant Ventricular Tachycardia

Chapter 263 | Part 6: Disorders of the Cardiovascular System

KEY CLINICAL POINTS

  • Electrical storm is defined as ≥ 3 episodes of ventricular tachycardia (VT) or ventricular fibrillation (VF) within 24 hours requiring intervention.
  • ICD shocks are associated with reduced quality of life and posttraumatic stress disorder; antitachycardia pacing reduces unnecessary shocks.
  • Management includes antiarrhythmic drugs (amiodarone, sotalol), catheter ablation, and ICD programming adjustments.
  • Polymorphic VT/VF in the setting of myocardial ischemia requires urgent revascularization and coronary intervention.
  • Special considerations include avoiding driving post-shock and managing QT prolongation with magnesium.

1. DEFINITION & OVERVIEW

Electrical storm refers to ≥ 3 episodes of VT/VF within 24 h requiring intervention. Incessant VT is defined as recurrent VT shortly after conversion to sinus rhythm. ICD shocks may indicate appropriate therapy or device malfunction. Prompt recognition is critical to prevent mortality.

Stabilize rhythm | Relieve triggers | Reduce sympathetic drive

Stabilize rhythm Relieve triggers Reduce sympathetic drive
Defibrillation Electrolyte management Beta blockers
Amiodarone Volume removal Sedation/intubation
Lidocaine Coronary revascularization Anxiolytics
Quinidine Pacing Quinidine
Ranolazine Mechanical support (ECMO/IABP) Ranolazine
Procainamide Catheter ablation Procainamide
Isoproterenol Stellate ganglion block (SGB) Isoproterenol
ECMO Cardiac surgical denervation Non-DHP CCB

1.1 Clinical Context

Electrical storm is uncommon in the general population but has high mortality without treatment. Incessant VT may be monomorphic or polymorphic, with monomorphic VT more amenable to ablation. ICD interrogation is essential post-shock to confirm appropriate therapy.

2. EPIDEMIOLOGY

Electrical storm occurs in 4% of patients with primary prevention ICDs, up to 20% with known VT history. Mortality is high without intervention. Risk factors include depressed ventricular function, ischemia, and proarrhythmic drugs (e.g., amiodarone).

2.1 Demographics

Common in patients with structural heart disease, myocardial infarction, or implantable cardioverter-defibrillator (ICD) recipients. Higher incidence in elderly and those with comorbidities.

3. ETIOLOGY & PATHOPHYSIOLOGY

Mechanisms include proarrhythmic effects of antiarrhythmics (e.g., amiodarone), ischemia-induced automaticity, and ICD-triggered arrhythmias. Incessant VT may result from reentry or triggered activity in scarred myocardium.

3.1 Proarrhythmic Effects

Drugs like amiodarone or flecainide may induce incessant VT. Ischemia can activate surviving Purkinje cells, leading to polymorphic VT/VF requiring frequent cardioversion.

4. CLINICAL FEATURES

Patients present with hemodynamic instability, chest pain, or syncope. ICD shocks may occur without symptoms. Recurrent VT/VF is often associated with underlying heart failure or ischemia.

4.1 Complications

Post-shock trauma, QT prolongation, and bradycardia from antiarrhythmics. Prolonged arrhythmia may lead to cardiogenic shock or cardiac arrest.

5. DIFFERENTIAL DIAGNOSIS

Differentiate between electrical storm and other arrhythmias (e.g., Brugada syndrome, long QT syndrome). Assess for ischemia, electrolyte abnormalities, or drug-induced proarrhythmia.

5.1 Key Differentiators

Polymorphic VT/VF in ischemia vs. idiopathic VF. PVC-initiated polymorphic VT may originate from scarred myocardium or fascicular tissue.

6. INVESTIGATIONS & DIAGNOSIS

ICD interrogation, ECG monitoring, and cardiac imaging (e.g., MRI) to identify scarred tissue. Laboratory tests include electrolytes, troponin, and magnesium levels.

6.1 Diagnostic Criteria

≥ 3 episodes of VT/VF within 24 h requiring intervention. ICD recordings may show antitachycardia pacing or shock delivery. Electrocardiograms may show monomorphic/polymorphic VT patterns.

7. MANAGEMENT & TREATMENT

Immediate interventions include defibrillation, antiarrhythmics (amiodarone, lidocaine), and ICD programming. Catheter ablation is preferred for monomorphic VT. Sympathetic blockade (e.g., SGB, epidural) may reduce arrhythmia burden.

Management Algorithm for Electrical Storm

Rhythm/Substrate Therapy
Monomorphic VT Beta-blockers, amiodarone, catheter ablation
Polymorphic VT (ischemic) Revascularization, magnesium, quinidine
Idiopathic VF Catheter ablation, SGB, antiarrhythmics
PVC-initiated polymorphic VT PVC ablation, antiarrhythmics
Long QT syndrome Magnesium, isoproterenol, avoid QT prolongation

7.1 Algorithm

Figure 263-4 outlines management based on rhythm and substrate: monomorphic VT (beta-blockers, amiodarone, ablation), polymorphic VT (revascularization, magnesium, quinidine), and idiopathic VF (ablation, SGB).

8. PROGNOSIS & COMPLICATIONS

Mortality is high without prompt intervention. Complications include ICD malfunction, post-shock trauma, and drug-induced bradycardia. Long-term outcomes depend on underlying cardiac function and arrhythmia control.

8.1 Long-Term Risks

Recurrence of VT/VF, heart failure exacerbation, and mortality from arrhythmia or ischemia. ICD programming optimization reduces unnecessary shocks.

9. SPECIAL CONSIDERATIONS

Avoid driving post-ICD shock. In patients with long QT syndrome, avoid QT prolonging drugs. Sympathetic blockade (e.g., SGB) may be used in refractory cases. Monitor for bradycardia with antiarrhythmic use.

9.1 Safety Precautions

Patients should not drive after receiving an ICD shock. Ischemia management is critical in acute coronary syndromes to prevent recurrent arrhythmias.

10. KEY POINTS & CLINICAL PEARLS

  • Electrical storm requires immediate defibrillation and antiarrhythmic therapy.
  • ICD interrogation is essential post-shock to confirm appropriate therapy.
  • Catheter ablation is first-line for monomorphic VT.
  • Sympathetic blockade (SGB, epidural) reduces arrhythmia burden.
  • Avoid QT prolonging drugs in long QT syndrome.